Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-20-003138
Filing Date
2020-02-28
Accepted
2020-02-28 16:05:37
Documents
12
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 form10ka.htm 10-K/A 365955
2 ex4-7.htm EX-4.7 32774
3 ex10-26.htm EX-10.26 7604
4 ex31-1.htm EX-31.1 18931
5 ex31-2.htm EX-31.2 19382
6 ex10-31_001.jpg GRAPHIC 112128
7 ex10-31_003.jpg GRAPHIC 73553
8 ex10-31_004.jpg GRAPHIC 107400
9 ex10-31_005.jpg GRAPHIC 125470
10 ex10-31_006.jpg GRAPHIC 124408
11 ex10-31_007.jpg GRAPHIC 121701
12 ex10-31_008.jpg GRAPHIC 66752
  Complete submission text file 0001493152-20-003138.txt   1453564
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

EIN.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K/A | Act: 34 | File No.: 001-36138 | Film No.: 20670020
SIC: 2834 Pharmaceutical Preparations